Cerebral Spinal Fluid (CSF) Management Market Size & Forecast By Product (CSF Shunts, CSF Drainage), By Region (North America, Europe, Asia Pacific, Row), And Trend Report

Cerebral Spinal Fluid (CSF) Management Market Size & Forecast By Product (CSF Shunts, CSF Drainage), By Region (North America, Europe, Asia Pacific, Row), And Trend Analysis From 2012 - 2022

Published: January 2017  |  64 Pages  |  Format: PDF  |  Report ID: GVR-1-68038-373-7

Industry Insights

The global Cerebral Spinal Fluid (CSF) management market size was valued at USD 879.1 million in 2014 and is projected to witness lucrative growth year on year growth. Unique nature of cerebrospinal fluid dynamics in each patient has challenged neurologists, neurosurgeons, and medical device developers. This has led to increasing demand for advanced CSF management devices.

Rapid advancements in ongoing research projects related to brain barriers and brain fluids are anticipated to impact the market growth to a large extent. These research projects are mainly aimed at management of hydrocephalus and other cerebro-spinal fluid associated disorders.

Europe CSF management market share, by CSF drainage product, 2012 - 2022

Europe CSF management market

These products have attracted a significant amount of attention owing to the potential prospects of the application in the treatment of hydrocephalus and other brain associated disorders. This is primarily attributable to the lack of proper treatment for such diseases, which prompts the neurologist to invest for the development of these products.

According to Hydrocephalus Association, nearly 700,000 older Americans are estimated to live with normal pressure hydrocephalus. Moreover, it is observed that one to two out of every 1,000 babies are born with this condition. Presence of such large population base suffering with the disease is expected to drive demand of these products and platforms.

Furthermore, conferences and workshops on basic science research and its translation into diagnosis and treatment of cerebrospinal fluid disorders are expected to propagate the growth in this segment of neurology devices. These conferences are intended to increase awareness amongst neurosurgeon, nurse practitioners, and physicians about current treatment options for such disorders and for the advancements in these options.

Product Insights

CSF shunts and drainage systems are used for the purpose of cerebro-spinal fluid management. Shunts are found to be useful for the diversion of CSF in a controlled manner away from the central nervous system (CNS) fluid compartments. It provides an alternative pathway for the fluid flow

Being the most conventional method, shunts captured the larger market share in terms of revenue generation. These shunts are considered as common and primary treatment/therapy for hydrocephalus management.

Moreover, technological advancements in these devices to combat the issues pertaining to biocompatibility, infection, and fouling is expected to contribute to future growth of this segment.

Drainage devices are expected to emerge as fastest growing segment over the forecast period. This is due to their wide spectrum application in monitoring several CSF related conditions. In addition, research in this segment to address the limitations associated with existing devices is expected to augment the progress of this segment. For instance, recently, BeckerSmith Medical, Inc. introduced first automated cerebral spinal fluid drain monitoring system that facilitates in the reduction of ICU workload and length of stay.

Development of platforms by identification and development of proprietary technologies for solving the unmet clinical needs and treating the chronic nervous ailments such as Subarachnoid hemorrhage and hydrocephalus is projected to fuel growth in this sector over the forecast period. Ongoing research for deriving and developing the application of the CSF management platforms in the treatment of neurotoxic diseases is attributive to drive industrial growth significantly.

Introduction and implementation of such platforms is anticipated to facilitate in less utilization of hospital resources by reduction in length of stay, improving clinical functional outcomes, and an overall reduced healthcare economic burden thus accelerating adoption rate.

Global CSF management market, by region, 2014 (USD Million)

>Global CSF management market

Regional Insights

North American region is expected to contribute the highest revenue over the forecast period as a result of increasing growth of geriatric population suffering from nervous disorders coupled with rising approvals by the U.S. FDA for new products. As of 2014, it held more 39.0% of the global market share.

Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing awareness about the neurological diseases and related treatment options in the region coupled with rising incidence of stroke disease. Increasing penetration of the Original Equipment Manufacturers in the developing economies to tap the potential market is anticipated to boost growth in this region.

Competitive Insights

Key players contributing in the market space include Magstim, B. Braun Melsungen AG; Johnson & Johnson Services, Inc; Integra LifeSciences Corporation;Spiegelberg GmbH & Co. KG; Medtronic, Inc.; Sophysa; Beckersmith Medical, Inc; Elekta AB; and Phoenix Biomedical Corp.

The companies are undertaking different strategic initiatives including mergers, acquisitions, regional expansion, new product development, and strategic collaboration in order to sustain their position in the market. For instance, in 2015, Codman Neuro (operating unit of Johnson & Johnson Services, Inc.) introduced a novel MRI-resistant programmable valve with eight different pressure settings that offers constant intra-ventricular pressure and CSF drainage for hydrocephalus treatment.

Report Scope 

Attribute

Details

Base year for estimation

2014

Actual estimates/Historical data

2012- 2016

Forecast period

2017- 2022

Market representation

Revenue in USD Million and CAGR from 2015 to 2022

Regional scope

North America, Europe, Asia Pacific, and ROW.

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you are looking for specific or additional market information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue growth at global & regional and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research has segmented the CSF management market on the basis of product and region:

  • Product Outlook (Revenue, USD Million; 2012 - 2022)

    • CSF shunts

    • CSF drainage

  • Regional Outlook (Revenue, USD Million; 2012 - 2022)

    • North America

    • Europe

    • Asia Pacific

    • RoW

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA